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Summary
Here we test the hypothesis that there are distinct tem-
poral patterns of synchronized neuronal activity in
the pallidum that characterize untreated and treated
parkinsonism and dystonia. To this end we recorded
local ®eld potentials (LFPs) from the caudal and rostral
contact pairs of macroelectrodes implanted into the pal-
lidum of patients for the treatment of Parkinson's
disease (12 cases recorded on and off medication, 17
macroelectrodes) and dystonia (10 cases, 19 macro-
electrodes). Percentage LFP power in the 11±30 Hz
band was decreased and that in the 4±10 Hz band
increased across both contact pairs in treated
Parkinson's disease compared with untreated
Parkinson's disease. Dystonic patients had even less
11±30 Hz power and greater 4±10 Hz power compared
with untreated or treated Parkinson's disease patients.
The change in the 4±10 Hz band in patients with dysto-
nia was particularly manifest in the more rostral con-
tact pair, presumed to be within or bridging the globus
pallidus externus. We conclude that untreated and trea-
ted Parkinson's disease and dystonia are characterized
by different spatiotemporal patterns of activity in the
human pallidum.
Keywords: local ®eld potentials; dystonia; Parkinson's disease
Abbreviations: A±D = analogue-to-digital conversion; GPe = globus pallidus externus; GPi = globus pallidus internus;
HFS = high-frequency stimulation; LFP = local ®eld potential; MPTP = 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;
STN = subthalamic nucleus
Introduction
High-frequency stimulation (HFS) of the pallidum has been
shown to be of therapeutic bene®t in the treatment of
Parkinson's disease (Siegfried and Lippitz, 1994; Bejjani
et al., 1997, 1998; Davis et al., 1997; Gross et al., 1997;
Pahwa et al., 1997; Siegfried and Wellis, 1997; Yelnik et al.,
2000) and dystonia (Kumar et al., 1999; Coubes et al., 2000).
In Parkinson's disease, stimulation of the pallidum improves
motor performance by 54% (SD 33%) on evaluation of the
UPDRS (Uni®ed Parkinson's Disease Rating Scale) Part III
(Volkmann et al., 2001) and may completely abolish
levodopa-induced dyskinesias (Krack et al., 1998a; Yelnik
et al., 2000). Generalized dystonia can be improved by up to
90% by pallidal stimulation (Kumar et al., 1999; Coubes
et al., 2000).
The therapeutic success of pallidal functional neurosurgery
for movement disorders has revealed two related paradoxes.
First, how does lesioning or HFS of one of the two major
out¯ow stations of the basal ganglia, the globus pallidus
internus (GPi), improve parkinsonism without any clear
deleterious effects upon motor function (Marsden and Obeso,
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 1994; Bar-Gad and Bergman, 2001)? Secondly, how do the
same interventions improve such disparate states as
parkinsonism (Baron et al., 1996; Tronnier et al., 1997;
Yelnik et al., 2000), dyskinesia (Baron et al., 1996; Krack
et al., 1998b; Yelnik et al., 2000) and dystonia (Tronnier and
Fogel, 2000; Coubes et al., 2000; Vercueil et al., 2001)?
It has been suggested that the ®rst of these paradoxes might
be explained if the parkinsonian state was characterized by
abnormal patterning of pallidal out¯ow, so that no activity is
better than bad or noisy activity, although the precise nature
of such abnormal patterning was not speci®ed (Marsden and
Obeso, 1994). In line with this, microelectrode studies from
the GPi in normal monkeys and monkeys treated with
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as
well as Parkinson's disease patients on and off levodopa
therapy have shown alterations not only in neuronal ®ring
rates but also in the temporal patterning and synchronization
of neuronal activity (Raz et al., 2000; Levy et al., 2001).
Local ®eld potential (LFP) recordings in the GPi, which
probably represent the product of synchronous activity in a
population of neurons (Brown et al., 2001), also demonstrate
an altered pattern of frequency-dependent coupling between
the GPi, the subthalamic nucleus (STN) and the motor cortex
in patients with Parkinson's disease, dependent on the
dopaminergic state (Cassidy et al., 2002; Williams et al.,
2002). Thus the bulk of evidence points to a difference in
patterning in the off and on states. The knock-on effects of
such patterning could be either obliterated by pallidotomy or
suppressed by high-frequency pallidal stimulation (Anderson
et al., 2003).
The paradoxical improvement in differing disease states
with pallidal lesions and stimulation might also be explained
if there was more than one type of abnormal patterning of
pallidal out¯ow. Here, the evidence is more limited, but in
dystonia patterns of neuronal discharge have been reported
that differ from those in normal primates (Lenz et al., 1999;
Vitek et al., 1999;), although the extent to which they may
differ from those in parkinsonian primates and Parkinson's
disease patients is unclear.
Here we test the hypothesis that there are distinct temporal
patterns of synchronized neuronal activity in the pallidum
that characterize parkinsonism and dystonia. LFPs were
recorded from the different contacts of macroelectrodes
inserted into the pallidum of patients for the treatment of
Parkinson's disease and dystonia. Patients were studied while
alert, during the interval between implantation and subse-
quent connection of the macroelectrode to a subcutaneous
stimulating device. By recording the LFP from macro-
electrode contacts rather than single-unit activity from
microelectrodes we were able to concentrate on changes in
the synchronous activity across many neurons, as unsyn-
chronized neuronal activity is cancelled out and lost in the
LFP. We focused our attention on LFP activity in the 4±10,
11±30 and 65±85 Hz bands, as past work suggests that these
activities may differ in functional signi®cance (Brown et al.,
2001; Williams et al., 2002). The results con®rm that
untreated Parkinson's disease, treated Parkinson's disease
and dystonia can be distinguished by the pattern of
synchronization of local activity evident in the LFPs recorded
from the human globus pallidus.
Methods
Patients and surgery
All patients participated with informed consent and with the
agreement of the joint ethical committee of the National
Hospital for Neurology and Neurosurgery and the Institute of
neurology, London; the Ethics Committee of The Clarite Â-
Universita Ètsmedizin, Berlin, Campus Virchow-Klinikum and
the Ethics Committee of the A. Alesini Hospital, Rome.
Clinical details are summarized in Table 1.
Indications for surgery were medication-refractory severe
dystonia and treatment-resistant Parkinson's disease with or
without levodopa-induced dyskinesias. Dyskinesias were
severe preoperatively in nine out of the 12 Parkinson's
disease patients (13 out of a total of 17 macroelectrodes in the
Parkinson's disease patients). Patients were recorded 1±6
days postoperatively, at a time when levodopa-induced
dyskinesias tended to be less evident because of temporary
microlesional effects. There was no difference in the delay
between surgery and recording between Parkinson's disease
(mean 3.4 days) and dystonic (mean 2.9 days) patients, and
Parkinson's disease patients were recorded on and off
medication on the same day. Off-period dystonias were not
seen in any of the Parkinson's disease patients during
recording. The operative procedure and bene®cial clinical
effects of stimulation have been described previously
(Siegfried and Lippitz, 1994; Volkmann et al., 1998, 2001).
Macroelectrodes were inserted bilaterally, with the exception
of six Parkinson's disease patients in whom implantation was
unilateral. The macroelectrode used was model Medtronic
3387 (Medtronic Neurological Division, Minneapolis, MN,
USA) with four platinum±iridium cylindrical surfaces
(1.27 mm diameter and 1.5 mm length) and centre-to-centre
separation of 3 mm. Contact 0 was the most caudal and
contact 3 was the most rostral. Macroelectrodes were
connected to a battery-operated programmable pulse-
generator (Itrel II or Kinetra 7428; Medtronic) after an
interval of 2±7 days. Eight of the nine dyskinetic patients
and all 10 dystonic patients improved following pallidal
stimulation.
Electrode placement
The intended coordinates at the tip of contact 0 were 19±
22 mm from the midline of the patient, 2±3 mm in front of the
midcommissural point and 6 mm below the anterior
commissure±posterior commissure line, i.e. within the GPi.
Under these circumstances, with a trajectory that is angled by
70±80° in the sagittal plane and by 75±85° in the coronal
plane, the most rostral contact pair is likely to lie in the globus
2598 P. Silberstein et al.
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 pallidus externus (GPe) (Yelnik et al., 2000; Peppe et al.,
2001). Intraoperatively, the correct placement of the elec-
trodes was veri®ed by teleradiography using ventriculo-
graphy, Guiot's landmarks/volumetric fusion and a long-
distance biorthogonal X-ray system. In addition, macro-
stimulation of the pallidum and surrounding structures,
including the internal capsule and the optic tract, was
performed intraoperatively. All patients received preopera-
tive high-resolution MRI. Postoperative imaging consisted of
CT (n = 2, Cases 12 and 13) or MRI (n =13, Cases 2, 4, 6, 9,
10, 14, 16±22). Where postoperative CT was performed, the
macroelectrode position was superimposed on preoperative
Fig. 1 Axial MRI sections of 3 mm thickness (0 mm between sections) presented rostrocaudally (A±D)i n
Case 14, with cervical dystonia. Contacts 01 are in the region of GPi (C, D) whereas contacts 23 are in
the region of GPe (A, B) bilaterally. The macroelectrode tip was visualized in the section below D (not
shown).
LFP in dystonia and Parkinson's disease 2599
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 MRI using image fusion systems. No postoperative imaging
was performed in seven cases (Cases 1, 3, 5, 7, 8, 11 and 15).
Postoperative imaging, where available, was consistent with
the placement of macroelectrode contacts 0 and/or 1 and 2
and/or 3 in the GPi and GPe/GPe±putamen border, respect-
ively (Fig. 1). Note that postoperative images have been
previously published in Cases 1 (Brown et al., 2001), 4
(Brown et al., 2002) and 13 (Brown et al., 2002).
Recordings
Subjects were seated or supine and recorded at rest. In the
parkinsonian patients, recordings were divided into those
performed in the practically de®ned off state, after overnight
withdrawal of antiparkinsonian medication, and those per-
formed over a period 45±135 min after ingestion of levodopa,
during the clinical effect of this drug. These states will be
termed `on' and `off' (drug). The mean test dose of levodopa
given in combination with a decarboxylase inhibitor was
200 mg. LFPs were recorded bipolarly from the adjacent four
contacts of each macroelectrode (0±1, 1±2, 2±3). They were
®ltered at 1±300 Hz and ampli®ed (3100 000 to 3500 000).
Signals were sampled at 1 kHz and monitored on-line.
Ampli®cation, ®ltering and recording were performed using a
custom-made 9 V battery-operated portable high-impedance
ampli®er (its front end input stage was the INA128 instru-
mentation ampli®er; Texas Instruments, Dallas, TX, USA)
and recorded through a 12-bit analogue-to-digital conversion
(A±D) card (PCM-DAS16S; ComputerBoards, Middleboro,
MA, USA) with a maximum throughput rate of 330 kHz, onto
a portable computer using a custom-written program in Berlin
(except in Cases 21 and 22, in whom A±D conversion was
performed with a CED 1401; Cambridge Electronic Design,
Cambridge, UK), Mannheim and Oxford. Ampli®cation,
®ltering and recording were performed using a Nicolet Viking
IIe and thereafter through an A±D card onto a portable
computer in Rome and, using a Schwartzer 34 ampli®er
system (Schwartzer Medical Diagnostic Equipment, Munich,
Germany) and Brainlab software (OSG, Rumst, Belgium) in
Amsterdam. With one exception, recordings were made by
either P.B. and/or A.A.K.
Analysis
Only LFPs recorded from contact pairs 01 and 23 were
analysed, as contacts 0 and/or 1 and 2 and/or 3 were likely to
be placed in GPi and GPe, respectively (see above) and did
not share a contact. LFPs were digitally ®ltered at 50 Hz. A
fast Fourier transform was performed on non-overlapping
sections of equal length using commercial software (Spike 4;
Cambridge Electronic Design). Results were averaged across
sections and the autospectra determined over 4±100 Hz. The
mean number of segments averaged was 800 per subject
(range 110±2200). Spectral estimates were derived from long
records, so that changes in power could have arisen from a
persistent change in activity or periods of altered activity.
Inspection of the signals suggested that the latter was only
important in the 4±10 Hz band, where bursts of activity were
frequently seen to last 1±4 s in dystonic patients. The segment
length used was 1024 points, giving a frequency bin size
approximating 1 Hz. Thus segment lengths were 1 s in
duration, so that signi®cant departures from local stationarity
within these blocks was unlikely, even in the case of the
4±10 Hz bursts. Power was expressed as the percentage of the
total power in the 4±45 and 55±100 Hz range in each subject
and summed across bins to give the percentage power in the
4±10, 11±30 and 65±85 Hz bands. These bands were chosen
on the basis of past work that suggests that these activities
may differ in functional signi®cance (Brown et al., 2001;
Williams et al., 2002). The 0±4 and 45±55 Hz ranges were
omitted so as to avoid inclusion of movement artefact and
mains noise, respectively. Relative rather than absolute power
was measured to allow comparison across disease groups, as
absolute power would be more likely to be dependent on
proximity to the LFP source than relative power and to vary
with minor changes in recording technique. At this stage it
remains unclear whether absolute or proportional changes in
neuronal synchronization across different frequency bands
are likely to be the more relevant to abnormal motor activity.
Statistical analysis was performed using a repeated measures
general linear model, as described in the Results section
(SPSS for Windows version 11; SSPS, Chicago, IL, USA).
Where results were non-spherical, Greenhouse±Geisser cor-
rection was used and the corrected degrees of freedom are
shown in the text. Post hoc paired and unpaired two-tailed t
tests were applied where appropriate. As multiple post hoc
tests were performed, signi®cance levels are presented with
Bonferroni correction. Discrete peaks in LFP power spectra
were de®ned as more than two contiguous bins with mean
power greater than twice that of the adjacent two contiguous
bins on each side.
Results
Representative autospectra, expressed as a percentage of the
total power up to 100 Hz, are shown for a patient with
Parkinson's disease (treated and untreated) and a patient with
dystonia in Fig. 2. The three candidate frequency bands (4±
10, 11±30 and 65±85 Hz) are shown by the boxed areas. A
discrete peak was found consistently only in the 11±30 Hz
band. Only ®ve Parkinson's disease patients showed a
discrete peak in the 65±85 Hz band, and this was present
only after drug treatment. A further two patients with
dystonia had a discrete peak in the 65±85 Hz band.
Comparison of LFPs in treated and untreated
Parkinson's disease
The percentages of total power picked up at 17 macro-
electrodes in 12 parkinsonian patients were entered into the
general linear model with frequency band (three levels: 4±10,
2600 P. Silberstein et al.
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 11±30 and 65±85 Hz), treatment state (two levels: on and off
levodopa) and contact pair (two levels: contacts 01 and 23)
as main effects. A signi®cant main effect for frequency
[F(1,19) = 47.841, P < 0.001] and signi®cant interactions
between drug state and frequency [F(1,19) = 9.510, P =
0.005] and between contact and frequency [F(1,22) = 6.663,
P = 0.011] were found. Post hoc analysis revealed an increase
in the relative power in the 4±10 Hz band (P < 0.05) and a
decrease in the 11±30 Hz band in the treated state (P < 0.05).
The interaction between contact and frequency across
treatment states was due to an increase in power in the 4±
10 Hz band at the most caudal contact, presumed to be in the
GPi (P < 0.01). The results are summarized in Fig. 3.
A subgroup analysis between LFPs recorded in untreated
Parkinson's disease patients with and without tremor was also
performed. The percentage of total power picked up at seven
macroelectrodes in ®ve tremulous patients was compared
with that in 10 macroelectrodes in seven non-tremulous
patients. The percentage of total power was entered into the
general linear model with frequency band (three levels: 4±10,
11±30 and 65±85 Hz), presence of tremor (two levels: tremor
and no tremor) and contact pair (two levels: contacts 01 and
23) as main effects. A signi®cant main effect for frequency
[F(1,17) = 46.514, P < 0.001] was found. No main effect for
tremor or signi®cant interactions were found.
Comparison of LFPs in untreated Parkinson's
disease and dystonia
The percentages of total LFP power detected at 19
macroelectrodes in the dystonic patients were compared
with those in the untreated parkinsonian patients. The
percentage of total power was entered into the general linear
model with frequency band (three levels: 4±10, 11±30 and
65±85 Hz), disease (two levels; untreated Parkinson's disease
and dystonia) and contact pair (two levels: contacts 01and 23)
as main effects. A signi®cant main effect for frequency
[F(1,41) = 90.169, P < 0.001] and a signi®cant interaction
between frequency and disease state [F(1,41) = 23.847, P <
0.001] were found. Post hoc analysis showed this to be due to
marked differences in power in the 4±10 Hz (P < 0.001) and
11±30 Hz bands (P < 0.0001). The results are summarized in
Fig. 3.
Comparison of LFPs in treated Parkinson's
disease and dystonia
The percentage of total LFP power picked up in the dystonic
patients was also compared with that in the treated
parkinsonian patients. The percentage of total power was
entered into the general linear model with frequency band
Fig. 2 Raw data and LFP autospectra in Case 11 with Parkinson's disease off (A, B, C) and on (D, E, F) levodopa and in Case 13 with
dystonia (G, H, I). Raw data (A, D, G) from electrode pairs 01 and 23 are labelled. LFP autospectra from contact pair 01 are shown in B,
E and H and from contact pair 23 in C, F and I. Autospectra are expressed as a percentage of total power up to 100 Hz. The three
candidate frequency bands, 4±10, 11±30 and 65±85 Hz, are shown by the boxed areas.
LFP in dystonia and Parkinson's disease 2601
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 (three levels: 4±10, 11±30 and 65±85 Hz), disease (two
levels: treated Parkinson's disease and dystonia) and contact
pair (two levels: contacts 01 and 23) as main effects. There
was a signi®cant main effect for frequency [F(1,43) = 82.310,
P < 0.001], a signi®cant two-way interaction between
frequency and disease [F(1,43) = 9.234, P = 0.002] and a
signi®cant three-way interaction between patient disease,
frequency and contact [F(2,56) = 4.063, P = 0.030]. Post hoc
tests indicated that the two-way interaction between fre-
quency and disease state was due to an increase in the 4±
10 Hz (P < 0.05) and a decrease in the 11±30 Hz (P < 0.01)
percentage power in the dystonic patients. The three-way
interaction between disease, frequency and contact was due to
an increase in the 4±10 Hz activity at the most rostral
electrode (P < 0.05). Finally, dystonic patients on medication
and those without medication at the time of recording
(Table 1) were compared using the general linear model.
There was a main effect for frequency [F(1,20) = 63.459, P <
0.001], but no signi®cant interactions involving treatment or
contact, suggesting that drug treatment did not affect our
results.
Discussion
We have demonstrated that untreated Parkinson's disease,
treated Parkinson's disease and dystonia can be distinguished
by the pattern of the LFP recorded from the human globus
pallidus. That ¯uctuations in the cortical LFP are linked to the
timing of synchronous neuronal discharges has been known
for some time (Creutzfeldt et al., 1966; Frost, 1968) but it has
only recently become evident that the same may be true of
LFP changes in the basal ganglia. Thus there is good
concordance between oscillations evident in LFPs and those
in single units (Goto and O'Donnell, 2001; Levy et al.,
2002a) and LFP ¯uctuations are tightly linked to postsynaptic
effects in terms of coupling between LFPs in distant sites
(Brown et al., 2001; Williams et al., 2002). Our results
therefore suggest that untreated Parkinson's disease, treated
Parkinson's disease and dystonia may be distinguished by
different patterns of synchronization of local activity within
the globus pallidus.
Figure 4 summarizes the core results. However, before
examining our ®ndings in detail, we should bear in mind
some of the potential limitations of our study.
Limitations of human recordings
One of the major limitations with pathophysiological inves-
tigations of patients receiving HFS is that the placement of
macroelectrodes within their targets is presumptive and not
backed up by histological con®rmation, as in animal studies.
Postoperative imaging cannot provide absolute con®rmation
of electrode placement and, even so, was available in only
70% of cases. We limited the effects of variance in electrode
positioning by recording many patients. To achieve this we
collaborated across several surgical centres, but this itself
introduced the possibility of systematic bias, albeit non-
intended, in the achieved target between centres.
On the other hand, the intended surgical coordinates were
the same across patients, postoperative imaging (where
available) was consistent with positioning of the distal
contacts of the macroelectrode in GPi, and all but one of
the dyskinetic parkinsonian patients and all of the dystonic
patients were clinically improved following deep-brain
stimulation, consistent with reasonable target accuracy. In
addition, two ®ndings point to some overall consistency of
electrode placement between patients. First, a signi®cant two-
way interaction between contact and frequency was seen
across treatment groups in Parkinson's disease, indicating
relatively consistent localization of macroelectrode contacts
between patients with Parkinson's disease. Secondly, a
signi®cant three-way interaction involving contact was
Fig. 3 Mean percentage total LFP power in (A) the 4±10 Hz and
(B) 11±30 Hz bands for contact pairs 01 and 23 in untreated and
treated Parkinson's disease and dystonia. Percentage power in the
4±10 Hz band is greater at contact pair 01 than 23 in treated and
untreated Parkinson's disease. Percentage power in the 4±10 and
11±30 Hz bands was increased and decreased, respectively, when
Parkinson's disease patients were treated. These power changes
were even more marked in dystonic patients, particularly at
contact 23. See Results section for statistical analysis. No
signi®cant effects were seen in the 65±85 Hz band and these data
are not illustrated. Error bars denote the standard errors of the
mean.
2602 P. Silberstein et al.
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 observed between treated Parkinson's disease and dystonic
patients, pointing to relatively consistent localization of
macroelectrode contacts within these patient groups.
Excessive variance in the position of each contact between
patients would have obviated any interactions involving
contact as a main effect. Nevertheless, the possibility that
differences between Parkinson's disease and dystonic
patients, which were treated largely at different centres,
arose from minor systematic bias in achieved targeting should
be borne in mind.
Another limitation in clinical studies is the inability to
entirely control for muscle activity. All our patients were
recorded at rest, but the three clinical groups are likely to have
had different degrees of involuntary activity: rigidity and rest
tremor in untreated parkinsonian patients, dyskinesias in
treated parkinsonian patients and spontaneous dystonic
activity in subjects with dystonia. The question therefore
arises whether differences in LFPs between the patient groups
were directly or indirectly responsible for the clinical
differences or were the product of the different patterns of
afferent activity accompanying the differing types of in-
voluntary muscle contraction. In practice, however,
levodopa-induced dyskinesias were diminished or absent at
the time of recording due to microlesional effects and there
was no difference between tremulous and non-tremulous
Parkinson's disease patients. Nevertheless, in the light of the
limitations discussed above we must be cautious in our
interpretation of differences in LFPs between clinical groups,
seeking, wherever possible, corroboration from animal
studies. In this regard it is particularly notable that our
®nding that LFP power is elevated in the 4±10 Hz band and
decreased in the beta band in dystonic patients compared with
either treated or untreated Parkinson's disease patients is
closely paralleled by the LFP changes in the globus pallidus
of the dtsz mutant hamster. This mutant has attacks of
predominantly sustained dystonic posturing lasting several
hours (Gernert et al., 1998). In this animal model of
paroxysmal dystonia, spectral changes in the theta and beta
bands persist between attacks, suggesting that the changes are
not a consequence of the attacks and accompanying afferent
activity.
It should also be noted that changes in the power at
4±10 Hz could have potentially included movement-related
artefact. This will have been limited by the fact that the
spectral content of dystonia and dyskinesias is generally
<4 Hz (Manson et al., 2000) and by our use of a differential
ampli®er. In practice, it also seems unlikely that changes in
the 4±10 Hz band were substantially affected by movement,
as differences tended to be asymmetrically distributed across
contacts.
The effect of levodopa upon LFPs in Parkinson's disease
was marked, raising the question whether drug treatments in
the dystonic patients may have accounted for the differences
between these and Parkinson's disease subjects. However, no
differences were found between treated and untreated
dystonic patients.
Finally, it should be remembered that recordings were
performed several days after implantation, when regional
oedema may still have been signi®cant, as suggested by the
microlesional effect noted in some patients. Nevertheless, the
delay between operation and recording did not differ
systematically between patient groups or across treatment
conditions in the same Parkinson's disease patients, so that it
cannot account for the spectral differences between or within
groups.
Pallidal LFP changes and bradykinesia
The ®nding of an increase in synchronization at 11±30 Hz
when Parkinson's disease patients were withdrawn from
levodopa is consistent with previous studies. Nini et al.
(1995) demonstrated a pronounced tendency towards syn-
chronization at frequencies <30 Hz in the primate GPi
following treatment with MPTP, which was not seen in
healthy monkeys (Nini et al., 1995). Microelectrode studies
in patients with Parkinson's disease have also demonstrated
synchronization of single units in the STN (Levy et al., 2000,
2002b) and GPi (Levy et al., 2001) at 11±30 Hz, particularly
in tremulous patients. Some of this synchronization of
pallidal activity may be related to the greater in¯uence of
striatal tonically active neurons in the parkinsonian state (Raz
et al., 2001). In addition, coherence (coupling) has been
Fig. 4 Intended orientation and localization of the macroelectrode shown superimposed on the traced
Schaltenbrand and Wahren atlas at the posterior commissure (PC) +20 mm (after Yelnik et al., 2000)
with a summary of the LFP ®ndings. Note that the 4±10 Hz activity is greater at the lower contact pair in
Parkinson's disease, but that this difference is lost in dystonia due to the greater increase in 4±10 Hz
activity at the rostral contact pair.
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 reported between LFPs in the STN and GPi at 11±30 Hz and
between these structures and the cerebral cortex in parkin-
sonian patients (Brown et al., 2001; Williams et al., 2002).
The LFP power and coupling in this frequency band are
attenuated by the ingestion of levodopa (in keeping with the
present results) and during movement (Cassidy et al., 2002;
Williams et al., 2002), leading to the hypothesis that activity
at 11±30 Hz may be essentially antikinetic in nature (Brown,
2003). If this is correct, pallidal functional neurosurgery
could improve parkinsonism without any clear deleterious
effects upon motor function by reducing an abnormal and
antikinetic patterning of pallidal out¯ow in the 11±30 Hz
band (Brown, 2003).
It is noteworthy that no difference emerged in pallidal
LFPs in the high gamma band (65±85 Hz) between treated
and untreated Parkinson's disease. This is in contrast to LFP
spectra from the human subthalamic nucleus, which com-
monly demonstrate a discrete peak in the high gamma band
following treatment with levodopa (Cassidy et al., 2002). The
result also contrasts with studies of the coherence between
LFPs in STN and GPi that show coupled activity in the high
gamma band following treatment (Brown et al., 2001).
However, as coherence is effectively normalized by auto-
spectral power, strong coupling may be evident despite very
little pallidal power at these frequencies. Neither is it
necessarily the case that an increase in the coupling between
spatially segregated neuronal populations in a particular band
should entail an increase in local synchronization at the same
frequency. Within the motor areas of the human cerebral
cortex, for example, local power and inter-regional coher-
ence/coupling may relate to different aspects of cortical
function that might, to some extent, operate independently of
each other (Gerloff et al., 1998).
It is also of interest that no difference was found between
tremulous and non-tremulous patients with respect to pro-
portional LFP power. A signi®cant postoperative reduction in
tremor due to microlesional effects in our tremulous patients
may potentially account for this, but, in addition, it seems
likely that tremor-synchronized pallidal oscillatory activity
makes only a small contribution to the LFP. Hutchison et al.
(1997) speci®cally searched for hand-related internal pallidal
cells with tremor-synchronized oscillatory activity in three
patients undergoing microelectrode exploration prior to
pallidotomy, but found such activity in only 12% of 228
neurons sampled. Raz and colleagues (Raz et al., 2000)
reported a 40% increase in oscillatory pallidal single-cell
activity after two vervet monkeys were treated with MPTP,
with frequencies distributed bimodally around 7 and 13 Hz.
They found that oscillatory activity and tremor were phasic
and dynamic phenomena and that in only 11% of records was
there signi®cant dependence between the timing of tremor
and neuronal oscillations. Hurtado et al. (1999), in their case
report of recordings from a single parkinsonian pallidum,
similarly found that single cells may, over time, oscillate in
both a phase-locked and an independent manner from limb
tremor at a single joint. Thus, whilst cells with tremor-
synchronized activity are clearly present in the parkinsonian
pallidum, they may make a relatively small contribution to
LFP rhythmicity. Our averaging over long segments, includ-
ing non-tremor periods, is further likely to have diminished
the impact of tremor-related oscillation on the LFP.
Pallidal LFP changes and hyperkinesia
Excessive movement (hyperkinesia) clearly dominated the
clinical picture in our dystonic patients, but was also present
in our Parkinson's disease patients when treated with
levodopa (although dyskinesias were often temporally sup-
pressed shortly after surgery). Thus, it is interesting that there
was a gradient of LFP change, whereby treated Parkinson's
disease patients had more 4±10 Hz and less 11±30 Hz activity
than untreated Parkinson's disease patients and dystonic
patients had more 4±10 Hz activity and less 11±30 Hz activity
than treated parkinsonian patients. These changes were even
more marked when compared with untreated Parkinson's
disease patients, consistent with the conclusion that the
difference in oscillatory activity between dystonia and
Parkinson's disease cannot be ascribed to treatment with
levodopa. As noted above, it has been suggested previously
that synchronization of neuronal activity at 11±30 Hz may
have an essentially antikinetic effect in the basal ganglia
(Brown, 2003). Consequently, the reduction in beta activity
amongst our treated Parkinson's disease and dystonic patients
may have contributed to hyperkinesia.
What is the possible basis for the 4±10 Hz LFP activity at
the neuronal level? Microelectrode studies demonstrate a
tendency for neuronal discharge in the GPi, and its input STN,
to occur in three modes: irregular, bursting (i.e. an inconstant
period of time between grouped discharges) and oscillatory
(Levy et al., 2001). The bursting and oscillatory modes, in
particular, are likely to have a major spectral content in the 4±
10 Hz band. The oscillatory mode is accompanied by a strong
tendency to synchronization between neurons at the fre-
quency of parkinsonian rest and action tremor, and is more
prominent in the untreated parkinsonian state (reviewed in
Brown, 2003). Presumably, therefore, the overall increase in
power at 4±10 Hz with levodopa treatment in Parkinson's
disease represents an exacerbation of the bursting mode. The
degree of synchronization between neurons during non-
oscillatory bursting is unclear, but the available evidence is in
favour of this mode actually increasing when parkinsonian
patients are treated with the dopamine agonist apomorphine
(Merello et al., 1999; Levy et al., 2001) or when MPTP-
treated green monkeys undergo STN lesioning (and become
dyskinetic but less tremulous) with ibotenic acid (Wichmann
et al., 1994). Indeed, bursting may be particularly prominent
during dyskinesias in primates and Parkinson's disease
patients (Yoshida, 1991; Levy et al., 2001) and during
hemiballismus (Suarez et al., 1997).
What is the evidence that non-oscillatory bursting is also a
feature of dystonia? In addition to changes in ®ring rate,
microelectrode recordings from the globus pallidus in
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 dystonic patients reveal marked abnormalities in the temporal
patterning of neuronal discharge, neurons ®ring in irregularly
grouped discharges with intermittent pauses (Lenz et al.,
1999; Vitek et al., 1999; Vitek, 2002). Furthermore, analysis
of interspike intervals in the endopeduncular nucleus (the
homologue of GPi) of dystonic dtsz hamsters shows an
increased proportion of neurons with a burst-like ®ring
pattern compared with normal animals (Gernert et al., 2002).
Evidence also exists from animal models of dystonia of burst
discharge in other nodes of corticobasal ganglionic loops
involved in motor control. Increased bursting has been noted
in the monkey motor thalamus after induction of dystonia by
intrathalamic injection of the GABA antagonist bicuculline
(Macia et al., 2002), and dystonic movements corresponding
to putaminal burst discharge have been seen after intra-
putaminal injection of bicuculline in the cat (Yamada et al.,
1995).
Together, these observations suggest that abnormal
neuronal bursting may be an important pathophysiological
substrate for the development of hyperkinesias, including
levodopa-induced dyskinesia and dystonia, and that this may
be related to the increase in 4±10 Hz activity in our
parkinsonian patients after treatment with levodopa and the
even greater relative 4±10 Hz activity in dystonic compared
with parkinsonian patients.
If this is correct, pallidal functional neurosurgery could
improve dyskinesias and dystonia (as opposed to parkinson-
ism) by reducing an abnormal pattern of pallidal out¯ow in
the 4±10 Hz band. Consonant with this is the report that
myoclonic dystonia is associated with a preponderance of
LFP power at 4±8 Hz in the pallidum (Liu et al., 2002). Note
that the presence of increased 4±10 Hz activity in patients in
whom surgery has led to a temporary amelioration of
dyskinesias through microlesional effects does not obviate
any association between these oscillations and the propensity
to dyskinesias. On the other hand, it does suggest that these
changes are not simply the consequence of hyperkinesia,
perhaps through afferent activity. Similar observations have
been made of the dystonic dtsz mutant hamster, in which
increases in LFP activity in the theta band occur during and
between paroxysmal hyperkinesias (Gernert et al., 1998).
Spatiotemporal differences between Parkinson's
disease and dystonia
Topographic differences in spectral activity were also noted
between macroelectrode contacts. In Parkinson's disease
patients there was a gradient of 4±10 Hz activity such that this
was maximal at the most caudal contact, whether or not
patients were treated. Interestingly, other studies have also
suggested that there may be functional topographic differ-
ences within the globus pallidus in Parkinson's disease
(Bejjani et al., 1997; Krack et al., 1998b; Yelnik et al., 2000).
In contrast, when dystonic patients were compared with
Parkinson's disease patients there was a general increase in
4±10 Hz activity that was most marked in the rostral contact
pair. As discussed in the Methods section, the likely
localization of one or both rostral contacts was the GPe,
and the localization of abnormalities to the GPe in dystonia is
not unprecedented. In humans, microelectrode studies have
shown changes in the frequency and pattern of neuronal ®ring
between the GPe and GPi. Mean ®ring rate is reduced in the
GPe but not the GPi in dystonia compared with Parkinson's
disease on medication (Lenz et al., 1998). Consistent with
this ®nding, the mean ®ring rate in the GPe was signi®cantly
lower than in the GPi in two out of the three cases of
generalized dystonia reported by Vitek et al. (1999).
Conclusion
In conjunction with other lines of evidence, our studies of
pallidal LFPs suggest that untreated Parkinson's disease is
associated with an increased tendency to synchronization
over the 11±30 Hz range and a decreased tendency to
synchronization at 4±10 Hz. The major change in dystonia is
a decrease in relative power in the 11±30 Hz band and an
increase in relative power in the 4±10 Hz range compared
with treated or untreated Parkinson's disease. The latter is
focused at macroelectrode contacts that are more likely to be
in the GPe than the GPi. The observations potentially offer an
explanation for two of the enduring paradoxes of pallidal
functional neurosurgery, namely, how this intervention
improves such disparate states as parkinsonism, levodopa
induced dyskinesias and dystonia, and how such improve-
ment is achieved without any clearly deleterious effects upon
motor function. It seems likely that each pathological state is
associated with its own abnormal spatiotemporal pattern of
pallidal activity, so that the success of functional neurosur-
gery may lie in the suppression of disruptive noisy activity
across a number of frequency bands.
Acknowledgements
We wish to thank David Williams, Gerard van Bruggen,
Andries Bosch and Hans Speelman for their help in recording
Case 15 and Klaus Niemann for his advice regarding imaging.
A.A.K. was supported by a fellowship to the German
Academic Exchange Service (DAAD).
References
Anderson ME, Postupna N, Ruffo M. Effects of high-frequency
stimulation in the internal globus pallidus on the activity of thalamic
neurons in the awake monkey. J Neurophysiol 2003; 89: 1150±60.
Bar-Gad I, Bergman H. Stepping out of the box: information
processing in the neural networks of the basal ganglia. Curr Opin
Neurobiol 2001; 11: 689±95.
Baron MS, Vitek JL, Bakay RA, Green J, Kaneoke Y, Hashimoto T,
et al. Treatment of advanced Parkinson's disease by posterior GPi
pallidotomy: 1-year results of a pilot study. Ann Neurol 1996; 40:
355±66.
2606 P. Silberstein et al.
b
y
 
g
u
e
s
t
 
o
n
 
N
o
v
e
m
b
e
r
 
3
,
 
2
0
1
4
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 Bejjani B, Damier P, Arnulf I, Bonnet AM, Vidailhet M, Dormont
D, et al. Pallidal stimulation for Parkinson's disease. Two targets?
Neurology 1997; 49: 1564±9.
Bejjani BP, Damier P, Arnulf I, Papadopoulos S, Bonnet AM,
Vidailhet M, et al. Deep brain stimulation in Parkinson's disease:
opposite effects of stimulation in the pallidum. Mov Disord 1998;
13: 969±70.
Brown P. Oscillatory nature of human basal ganglia activity:
relationship to the pathophysiology of Parkinson's disease. Mov
Disord 2003; 18: 357±63.
Brown P, Oliviero A, Mazzone P, Insola A, Tonali P, Di Lazzaro,
V. Dopamine dependency of oscillations between subthalamic
nucleus and pallidum in Parkinson's disease. J Neurosci 2001; 21:
1033±8.
Brown P, Williams D, Aziz T, Mazzone P, Oliviero A, Insola A,
et al. Pallidal activity recorded in patients with implanted electrodes
predictively correlates with eventual performance in a timing task.
Neurosci Lett 2002; 330: 188±92.
Cassidy M, Mazzone P, Oliviero A, Insola A, Tonali P, Di Lazzaro
V, et al. Movement-related changes in synchronization in the
human basal ganglia. Brain 2002; 125: 1235±46.
Coubes P, Roubertie A, Vayssiere N, Hemm S, Echenne B.
Treatment of DYT1-generalised dystonia by stimulation of the
internal globus pallidus. Lancet 2000; 355: 2220±1.
Creutzfeldt OD, Watanabe S, Lux HD. Relations between EEG
phenomena and potentials of single cortical cells. I. Evoked
responses after thalamic and epicortical stimulation.
Electroencephalogr Clin Neurophysiol 1966; 20: 1±18.
Davis KD, Taub E, Houle S, Lang AE, Dostrovsky JO, Tasker RR,
et al. Globus pallidus stimulation activates the cortical motor
system during alleviation of parkinsonian symptoms. Nat Med
1997; 3: 671±4.
Frost JD Jr. EEG±intracellular potential relationships in isolated
cerebral cortex. Electroencephalogr Clin Neurophysiol 1968; 24:
434±43.
Gerloff C, Uenishi N, Hallett M. Cortical activation during fast
repetitive ®nger movements in humans: dipole sources of steady-
state movement-related cortical potentials. J Clin Neurophysiol
1998; 15: 502±13.
Gernert M, Richter A, Rundfeldt C, Loscher W. Quantitative EEG
analysis of depth electrode recordings from several brain regions of
mutant hamsters with paroxysmal dystonia discloses frequency
changes in the basal ganglia. Mov Disord 1998; 13: 509±21.
Gernert M, Bennay M, Fedrowitz M, Rehders JH, Richter A.
Altered discharge pattern of basal ganglia output neurons in an
animal model of idiopathic dystonia. J Neurosci 2002; 22:
7244±53.
Goto Y, O'Donnell P. Network synchrony in the nucleus
accumbens in vivo. J Neurosci 2001; 21: 4498±504.
Gross C, Rougier A, Guehl D, Boraud T, Julien J, Bioulac B. High-
frequency stimulation of the globus pallidus internalis in
Parkinson's disease: a study of seven cases. J Neurosurg 1997;
87: 491±8.
Hurtado JM, Gray CM, Tamas LB, Sigvardt KA. Dynamics of
tremor-related oscillations in the human globus pallidus: a single
case study. Proc Natl Acad Sci USA 1999; 96: 1674±9.
Hutchison WD, Lozano AM, Tasker RR, Lang AE, Dostrovsky JO.
Identi®cation and characterization of neurons with tremor-
frequency activity in human globus pallidus. Exp Brain Res 1997;
113: 557±63.
Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A,
et al. Subthalamic nucleus or internal pallidal stimulation in young
onset Parkinson's disease. Brain 1998a; 121: 451±7.
Krack P, Pollak P, Limousin P, Hoffmann D, Benazzouz A, Le Bas
JF, et al. Opposite motor effects of pallidal stimulation in
Parkinson's disease. Ann Neurol 1998b; 43: 180±92.
Kumar R, Dagher A, Hutchison WD, Lang AE, Lozano AM.
Globus pallidus deep brain stimulation for generalized dystonia:
clinical and PET investigation. Neurology 1999; 53: 871±4.
Lenz FA, Suarez JI, Metman LV, Reich SG, Karp BI, Hallett M,
et al. Pallidal activity during dystonia: somatosensory
reorganisation and changes with severity. J Neurol Neurosurg
Psychiatry 1998; 65: 767±70.
Lenz FA, Jaeger CJ, Seike MS, Lin YC, Reich SG, DeLong MR,
et al. Thalamic single neuron activity in patients with dystonia:
dystonia-related activity and somatic sensory reorganization. J
Neurophysiol 1999; 82: 2372±92.
Levy R, Hutchison WD, Lozano AM, Dostrovsky JO. High-
frequency synchronization of neuronal activity in the subthalamic
nucleus of parkinsonian patients with limb tremor. J Neurosci 2000;
20: 7766±75.
Levy R, Dostrovsky JO, Lang AE, Sime E, Hutchison WD, Lozano
AM. Effects of apomorphine on subthalamic nucleus and globus
pallidus internus neurons in patients with Parkinson's disease. J
Neurophysiol 2001; 86: 249±60.
Levy R, Ashby P, Hutchison WD, Lang AE, Lozano AM,
Dostrovsky JO. Dependence of subthalamic nucleus oscillations
on movement and dopamine in Parkinson's disease. Brain 2002a;
125: 1196±209.
Levy R, Hutchison WD, Lozano AM, Dostrovsky JO. Synchronized
neuronal discharge in the basal ganglia of parkinsonian patients is
limited to oscillatory activity. J Neurosci 2002b; 22: 2855±61.
Liu X, Grif®n IC, Parkin SG, Miall RC, Rowe JG, Gregory RP, et al.
Involvement of the medial pallidum in focal myoclonic dystonia: a
clinical and neurophysiological case study. Mov Disord 2002; 17:
346±53.
Macia F, Escola L, Guehl D, Michelet T, Bioulac B, Burbaud P.
Neuronal activity in the monkey motor thalamus during bicuculline-
induced dystonia. Eur J Neurosci 2002; 15: 1353±62.
Manson AJ, Brown P, O'Sullivan JD, Asselman P, Buckwell D,
Lees AJ. An ambulatory dyskinesia monitor. J Neurol Neurosurg
Psychiatry 2000; 68: 196±201.
Marsden CD, Obeso JA. The functions of the basal ganglia and the
paradox of stereotaxic surgery in Parkinson's disease. Brain 1994;
117: 877±97.
Merello M, Balej J, Del®no M, Cammarota A, Betti O, Leiguarda
LFP in dystonia and Parkinson's disease 2607
b
y
 
g
u
e
s
t
 
o
n
 
N
o
v
e
m
b
e
r
 
3
,
 
2
0
1
4
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 R. Apomorphine induces changes in GPi spontaneous out¯ow in
patients with Parkinson's disease. Mov Disord 1999; 14:
45±9.
Nini A, Feingold A, Slovin H, Bergman H. Neurons in the globus
pallidus do not show correlated activity in the normal monkey, but
phase-locked oscillations appear in the MPTP model of
parkinsonism. J Neurophysiol 1995; 74: 1800±5.
Pahwa R, Wilkinson S, Smith D, Lyons K, Miyawaki E, Koller WC.
High-frequency stimulation of the globus pallidus for the treatment
of Parkinson's disease. Neurology 1997; 49: 249±53.
Peppe A, Pierantozzi M, Altibrandi MG, Giacomini P, Stefani A,
Bassi A, et al. Bilateral GPi DBS is useful to reduce abnormal
involuntary movements in advanced Parkinson's disease patients,
but its action is related to modality and site of stimulation. Eur J
Neurol 2001; 8: 579±86.
Raz A, Vaadia E, Bergman H. Firing patterns and correlations of
spontaneous discharge of pallidal neurons in the normal and the
tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet
model of parkinsonism. J Neurosci 2000; 20: 8559±71.
Raz A, Frechter-Mazar V, Feingold A, Abeles M, Vaadia E,
Bergman H. Activity of pallidal and striatal tonically active neurons
is correlated in mptp-treated monkeys but not in normal monkeys. J
Neurosci 2001; 21: RC128.
Siegfried J, Lippitz B. Bilateral chronic electrostimulation of
ventroposterolateral pallidum: a new therapeutic approach for
alleviating all parkinsonian symptoms. Neurosurgery 1994; 35:
1126±9.
Siegfried J, Wellis G. Chronic electrostimulation of
ventroposterolateral pallidum: follow-up. Acta Neurochir Suppl
(Wien) 1997; 68: 11±3.
Suarez JI, Metman LV, Reich SG, Dougherty PM, Hallett M, Lenz
FA. Pallidotomy for hemiballismus: ef®cacy and characteristics of
neuronal activity. Ann Neurol 1997; 42: 807±11.
Tronnier VM, Fogel W. Pallidal stimulation for generalized
dystonia. Report of three cases. J Neurosurg 2000; 92: 453±6.
Tronnier VM, Fogel W, Kronenbuerger M, Steinvorth S. Pallidal
stimulation: an alternative to pallidotomy? J Neurosurg 1997; 87:
700±5.
Vercueil L, Pollak P, Fraix V, Caputo E, Moro E, Benazzouz A,
et al. Deep brain stimulation in the treatment of severe dystonia. J
Neurol 2001; 248: 695±700.
Vitek JL. Pathophysiology of dystonia: a neuronal model. Mov
Disord 2002; 17 Suppl 3: S49±S62.
Vitek JL, Chockkan V, Zhang JY, Kaneoke Y, Evatt M, DeLong
MR, et al. Neuronal activity in the basal ganglia in patients with
generalized dystonia and hemiballismus. Ann Neurol 1999; 46: 22±
35.
Volkmann J, Sturm V, Weiss P, Kappler J, Voges J, Koulousakis A,
et al. Bilateral high-frequency stimulation of the internal globus
pallidus in advanced Parkinson's disease. Ann Neurol 1998; 44:
953±61.
Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V.
Safety and ef®cacy of pallidal or subthalamic nucleus stimulation in
advanced PD. Neurology 2001; 56: 548±51.
Wichmann T, Bergman H, DeLong MR. The primate subthalamic
nucleus. III. Changes in motor behavior and neuronal activity in the
internal pallidum induced by subthalamic inactivation in the MPTP
model of parkinsonism. J Neurophysiol 1994; 72: 521±30.
Williams D, Tijssen M, Van Bruggen G, Bosch A, Insola A, Di
Lazzaro V, et al. Dopamine-dependent changes in the functional
connectivity between basal ganglia and cerebral cortex in humans.
Brain 2002; 125: 1558±69.
Yamada H, Fujimoto K, Yoshida M. Neuronal mechanism
underlying dystonia induced by bicuculline injection into the
putamen of the cat. Brain Res 1995; 677: 333±6.
Yelnik J, Damier P, Bejjani BP, Francois C, Gervais D, Dormont D,
et al. Functional mapping of the human globus pallidus: contrasting
effect of stimulation in the internal and external pallidum in
Parkinson's disease. Neuroscience 2000; 101: 77±87.
Yoshida M. The neuronal mechanism underlying parkinsonism and
dyskinesia: differential roles of the putamen and caudate nucleus.
Neurosci Res 1991; 12: 31±40.
Received March 20, 2003. Revised June 2, 2003.
Accepted June 15, 2003
2608 P. Silberstein et al.
b
y
 
g
u
e
s
t
 
o
n
 
N
o
v
e
m
b
e
r
 
3
,
 
2
0
1
4
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 